ALPS Medical Breakthroughs ETF Rating $26.48 +0.53 (+2.04%) As of 04/17/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.90Holdings in SBIO have an aggregate rating of Moderate Buy based on 467 analyst ratings issued in the past year covering 50 companies (87.1% of the portfolio).SBIO Aggregate Price Target$26.48High Prediction$26.48Average Prediction$26.48Low Prediction$26.48Holdings in SBIO have an aggregate price target of $26.48 and a range of $26.48 to $26.48 covering 50 companies (87.1% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy32 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.66%VRNAVerona Pharma$58.92+1.1%2.9275 of 5 stars3.17$74.67 26.7%6News CoveragePositive NewsGap Down4.43%AXSMAxsome Therapeutics$104.460.0%4.5797 of 5 stars3.00$169.80 62.6%16Analyst RevisionPositive News4.27%ALKSAlkermes$27.05-0.5%4.6942 of 5 stars2.67$38.50 42.3%12Short Interest ↓Analyst Revision3.79%RYTMRhythm Pharmaceuticals$61.74+0.7%3.963 of 5 stars3.00$74.92 21.4%13Analyst Revision3.56%PTCTPTC Therapeutics$47.39+2.1%3.865 of 5 stars2.53$63.77 34.6%15Upcoming EarningsShort Interest ↑News Coverage3.08%RNAAvidity Biosciences$26.66+3.5%2.1801 of 5 stars3.00$66.69 150.2%13Positive News3.06%ZLABZai Lab$28.84-0.3%2.8656 of 5 stars2.75$47.37 64.2%4Gap Up2.92%AKROAkero Therapeutics$37.63+0.5%4.2284 of 5 stars3.00$76.29 102.7%9Insider TradePositive NewsGap Up2.92%MRUSMerus$43.06+2.7%2.7246 of 5 stars3.13$85.31 98.1%16News CoveragePositive News2.86%PTGXProtagonist Therapeutics$46.28+1.0%3.7978 of 5 stars3.00$65.44 41.4%9News CoveragePositive News2.64%CRNXCrinetics Pharmaceuticals$30.42+2.8%3.5052 of 5 stars2.92$73.00 140.0%13Positive News2.42%XENEXenon Pharmaceuticals$35.14+4.0%2.7344 of 5 stars3.00$56.78 61.6%10Analyst DowngradeOptions VolumeAnalyst RevisionNews Coverage2.36%ACADACADIA Pharmaceuticals$14.73+1.1%4.0203 of 5 stars2.50$23.93 62.5%16Analyst RevisionNews CoveragePositive NewsGap Down2.29%MLTXMoonLake Immunotherapeutics$38.33+3.7%2.1457 of 5 stars3.00$80.50 110.0%8Positive NewsGap Up2.02%FOLDAmicus Therapeutics$6.83+1.9%4.0484 of 5 stars2.78$16.75 145.2%9Positive News2.01%VCELVericel$41.23+1.0%2.6953 of 5 stars3.00$60.86 47.6%7News CoveragePositive News1.93%DNLIDenali Therapeutics$12.74+1.5%4.0123 of 5 stars3.00$37.57 194.9%171.81%TARSTarsus Pharmaceuticals$49.25-0.3%2.8812 of 5 stars3.00$63.67 29.3%7News CoveragePositive News1.81%MIRMMirum Pharmaceuticals$39.10+0.9%3.9341 of 5 stars3.09$58.20 48.8%11Analyst RevisionNews CoveragePositive News1.65%NAMSNewAmsterdam Pharma$16.34+1.9%2.4482 of 5 stars3.00$43.33 165.2%6Short Interest ↑1.55%AGIOAgios Pharmaceuticals$27.66+1.9%3.8373 of 5 stars2.56$56.57 104.5%91.52%GLPGGalapagos$24.66+0.7%0.6714 of 5 stars1.50$25.33 2.7%8Upcoming EarningsNews Coverage1.50%CGONCG Oncology$20.64+2.1%1.3399 of 5 stars3.00$59.33 187.5%11Analyst ForecastNews Coverage1.49%BCRXBioCryst Pharmaceuticals$7.40+2.5%4.0964 of 5 stars2.86$15.57 110.4%7Analyst Revision1.44%APGEApogee Therapeutics$33.11+3.3%2.1543 of 5 stars3.00$92.17 178.4%6News CoveragePositive News1.39%IRONDisc Medicine$42.17+2.9%2.6645 of 5 stars3.09$93.80 122.4%11Positive News1.38%IDYAIDEAYA Biosciences$17.08+5.6%3.5783 of 5 stars2.93$53.58 213.7%15Positive News1.35%MNKDMannKind$4.54+0.2%2.1138 of 5 stars3.22$9.56 110.6%91.32%VERAVera Therapeutics$21.29+0.2%2.7594 of 5 stars3.20$64.67 203.7%10Positive News1.30%IMCRImmunocore$28.41+1.9%2.5942 of 5 stars2.54$63.73 124.3%131.21%CLDXCelldex Therapeutics$18.30+2.8%2.6671 of 5 stars2.89$54.33 196.9%91.17%EWTXEdgewise Therapeutics$13.41+2.9%2.2761 of 5 stars2.75$40.38 201.2%8Gap Up1.12%LQDALiquidia$13.72+0.3%2.2558 of 5 stars3.11$26.63 94.1%9Insider TradeNews Coverage1.08%GPCRStructure Therapeutics$21.76+17.4%2.4355 of 5 stars3.00$81.29 273.6%8News CoverageGap UpHigh Trading Volume1.04%VRDNViridian Therapeutics$13.13+3.8%1.1705 of 5 stars2.75$35.70 171.9%12News CoveragePositive News1.01%AUPHAurinia Pharmaceuticals$7.76+1.2%2.7518 of 5 stars3.00$11.50 48.2%2News CoveragePositive NewsGap Up0.96%NVAXNovavax$6.00-3.2%3.571 of 5 stars2.43$18.00 200.0%7Options VolumeAnalyst Revision0.81%RCUSArcus Biosciences$7.89+0.4%2.4228 of 5 stars3.00$30.25 283.6%100.76%VIRVir Biotechnology$5.50+1.3%2.6029 of 5 stars2.86$33.57 510.4%7Analyst ForecastShort Interest ↑News Coverage0.75%NTLAIntellia Therapeutics$7.23+5.4%4.3362 of 5 stars2.63$37.56 419.4%19Gap Up0.72%AVXLAnavex Life Sciences$8.95+1.2%3.4266 of 5 stars3.33$44.00 391.6%3Gap Down0.69%DAWNDay One Biopharmaceuticals$6.84+1.2%2.6997 of 5 stars3.13$32.29 372.0%8Positive News0.67%PHVSPharvaris$14.00+2.0%1.3254 of 5 stars3.00$40.50 189.3%40.65%NUVBNuvation Bio$1.97+4.5%2.5112 of 5 stars3.25$8.75 345.3%4Positive News0.65%XNCRXencor$9.70+1.9%3.4862 of 5 stars3.14$33.86 249.0%7News Coverage0.63%MLYSMineralys Therapeutics$13.35-1.1%2.3964 of 5 stars3.00$33.00 147.2%3Insider TradeShort Interest ↑News Coverage0.62%AVBPArriVent BioPharma$18.14+1.3%1.1783 of 5 stars3.17$39.00 115.0%60.61%IMNMImmunome$7.91+10.3%2.5743 of 5 stars3.00$25.14 217.9%7Positive News0.60%DNTHDianthus Therapeutics$19.50+2.7%2.0981 of 5 stars3.22$54.33 178.6%9News CoveragePositive News0.58%PRAXPraxis Precision Medicines$33.79+13.3%3.1181 of 5 stars2.78$123.33 265.0%9News CoveragePositive News This page (NYSEARCA:SBIO) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBIO Stock Free SBIO Stock Alerts